Andreas Möller

16PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrical energy generation (incl. renewables, excl. photovoltaics)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 16, 2026
Intercellular Transfer of CD155 Mediated by Melanoma Extracellular Vesicles Downregulates DNAM-1 Expression on NK Cells.

|Jul 28, 2026
Identification of von Willebrand Factor-Enriched Small Extracellular Vesicles as a Blood-Based Biomarker for the Detection of Head and Neck Squamous Cell Carcinoma.

|Jun 03, 2026
Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy.

|May 28, 2026
Impact of Isolation Techniques on the Content of Small Extracellular Vesicles.

|Jun 19, 2024
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.

Li-Ying Wu, Su-Ho Park, Haakan Jakobsson

|Jan 18, 2024
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers.

Predrag Kalaba, Cristina Sanchez de la Rosa, Andreas Möller

Pageof 3

Frequent Collaborators

3 joint publications

Richard Lobb

3 joint publications

Li-Ying Wu

2 joint publications

Markus Muttenthaler

2 joint publications

Yue Su